Polyelectrolyte multilayer coating with two regulatory molecules on titanium: Construction and its biological effects

Nanomedicine

Volumn 8, Issue 5, 2013, Pages 739-755

  Luo, Qiaojie ^a   Huang, Ying ^a   Deng, Xuliang ^b   Zhang, Jianxiang ^c   Li, Xiaohui ^c   Zhao, Shifang ^a   Li, Xiaodong ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

bFGF; osseointegration; polyelectrolyte multilayer; RGD; synergistic effect

Indexed keywords

ARGININE; ASPARTIC ACID; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; COLLAGEN TYPE 1; FLUORESCEIN ISOTHIOCYANATE; GLYCINE; HYALURONIC ACID; OSTEOCALCIN; POLYELECTROLYTE; TITANIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE IMPLANT; BONE REGENERATION; CHEMICAL COMPOSITION; CROSS LINKING; DISULFIDE BOND; FEMUR; MATERIAL COATING; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 84877643237     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.151     Document Type: Article

References (55)

1. Cooper LF. Biologic determinants of bone formation for osseointegration: clues for future clinical improvements. J. Prosthet. Dent. 80(4), 439-449 (1998).
2. Boyan BD, Schwartz Z, Hambleton JC. Response of bone and cartilage cells to biomaterials in vivo and in vitro. J. Oral Implantol. 19(2), 116-122 (1993).
3. Stanford CM, Johnson GK, Fakhry A, Gratton D, Mellonig JT, Wanger W. Outcomes of a fluoride modified implant one year after loading in the posterior-maxilla when placed with the osteotome surgical technique. Appl. Osseointegration Res. 5, 50-55 (2006).
4. Avila G, Misch K, Galindo-Moreno P, Wang HL. Implant surface treatment using biomimetic agents. Implant. Dent. 18(1), 17-26 (2009).
5. Masi L, Franchi A, Santucci M et al. Adhesion, growth, and matrix production by osteoblasts on collagen substrata. Calcif. Tissue Int. 51(3), 202-212 (1992).
6. Schuler M, Owen GR, Hamilton DW et al. Biomimetic modification of titanium dental implant model surfaces using the RGDSP-peptide sequence: a cell morphology study. Biomaterials 27(21), 4003-4015 (2006).
7. Bagno A, Piovan A, Dettin M et al. Human osteoblast-like cell adhesion on titanium substrates covalently functionalized with synthetic peptides. Bone 40(3), 693-699 (2007).
8. Yliheikkila PK, Masuda T, Ambrose WW, Suggs CA, Felton DA, Cooper LF. Preliminary comparison of mineralizing multilayer cultures formed by primary fetal bovine mandibular osteoblasts grown on titanium, hydroxyapatite, and glass substrates. Int. J. Oral Maxillofac. Implants 11(4), 456-465 (1996).
9. Grzesik WJ, Robey PG. Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J. Bone Miner. Res. 9(4), 487-496 (1994).
10. D'souza SE, Ginsberg MH, Plow EF. Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif. Trends Biochem. Sci. 16(7), 246-250 (1991).
11. Andrade FK, Moreira SMG, Domingues L, Gama FMP: improving the affinity of fibroblasts for bacterial cellulose using carbohydrate-binding modules fused to RGD. J. Biomed. Mater. Res. A 92A(1), 9-17 (2010).
12. Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309(5963), 30-33 (1984).
13. El-Ghannam AR, Ducheyne P, Risbud M et al. Model surfaces engineered with nanoscale roughness and RGD tripeptides promote osteoblast activity. J. Biomed. Mater. Res. A 68A(4), 615-627 (2004).
14. Rezania A, Healy KE. The effect of peptide surface density on mineralization of a matrix deposited by osteogenic cells. J. Biomed. Mater. Res. 52(4), 595-600 (2000).
15. Chua PH, Neoh KG, Kang ET, Wang W. Surface functionalization of titanium with hyaluronic acid/chitosan polyelectrolyte multilayers and RGD for promoting osteoblast functions and inhibiting bacterial adhesion. Biomaterials 29(10), 1412-1421 (2008).
16. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr. Rev. 8(2), 95-114 (1987).
17. Kurane A, Simionescu DT, Vyavahare NR. In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor. Biomaterials 28(18), 2830-2838 (2007).
18. Pacicca DM, Patel N, Lee C et al. Expression of angiogenic factors during distraction osteogenesis. Bone 33(6), 889-898 (2003).
19. Pitaru S, Kotev-Emeth S, Noff D, Kaffuler S, Savion N. Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: enhanced development of mineralized bone-like tissue in culture. J. Bone Miner. Res. 8(8), 919-929 (1993).
20. Nagai H, Tsukuda R, Mayahara H. Effects of basic fibroblast growth factor (bFGF) on bone formation in growing rats. Bone 16(3), 367-373 (1995).
21. Kawaguchi H, Kurokawa T, Hanada K et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135(2), 774-781 (1994).
22. Abbaspour A, Takata S, Sairyo K, Katoh S, Yukata K, Yasui N. Continuous local infusion of fibroblast growth factor-2 enhances consolidation of the bone segment lengthened by distraction osteogenesis in rabbit experiment. Bone 42(1), 98-106 (2008).
23. Sahoo S, Toh SL, Goh JCH. A bFGF-releasing silk/PLGA-based biohybrid scaffold for ligament/tendon tissue engineering using mesenchymal progenitor cells. Biomaterials 31(11), 2990-2998 (2010).
24. Decher G. Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science 277(5330), 1232-1237 (1997).
25. Li XJ, Luo Q J, Huang Y, Li XD, Zhang F, Zhao SF. The responses of preosteoblasts to collagen/hyaluronic acid polyelectrolyte multilayer coating on titanium. Polym. Adv. Technol. 23(4), 756-764 (2012).
26. Huang Y, Luo Q, Li X, Zhang F, Zhao S. Fabrication and in vitro evaluation of the collagen/hyaluronic acid PEM coating crosslinked with functionalized RGD peptide on titanium. Acta Biomater. 8(2), 866-877 (2011).
27. Nkenke E, Kloss F, Wiltfang R et al. Histomorphometric and fluorescence microscopic analysis of bone remodelling after installation of implants using an osteotome technique. Clin. Oral Implants Res. 13(6), 595-602 (2002).
28. Jones E, Yang X. Mesenchymal stem cells and bone regeneration: current status. Injury 42(6), 562-568 (2011).
29. Puleo DA, Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 20(23-24), 2311-2321 (1999).
30. Cooper LF, Masuda T, Yliheikkila PK, Felton DA. Generalizations regarding the process and phenomenon of osseointegration. Part II. In vitro studies. Int. J. Oral Max. Impl. 13(2), 163-174 (1998).
31. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 21(17), 1803-1810 (2000).
32. Webster TJ, Siegel RW, Bizios R. Osteoblast adhesion on nanophase ceramics. Biomaterials 20(13), 1221-1227 (1999).
33. Caetano-Lopes J, Canhao H, Fonseca JE. Osteoblasts and bone formation. Acta Reumatol. Port. 32(2), 103-110 (2007).
34. Saito G, Swanson JA, Lee KD. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv. Drug Deliver. Rev. 55(2), 199-215 (2003).
35. Zelikin AN, Quinn JF, Caruso F. Disulfide crosslinked polymer capsules: en route to biodeconstructible systems. Biomacromolecules 7(1), 27-30 (2006).
36. Pierschbacher MD, Ruoslahti E. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J. Biol. Chem. 262(36), 17294-17298 (1987).
37. Decher G, Lvov Y, Schmitt J. Proof of multilayer structural organization in self-assembled polycation-polyanion molecular films. Thin Solid Films 244(1-2), 772-777 (1994).
38. Shechter Y, Burstein Y, Patchornik A. Selective oxidation of methionine residues in proteins. Biochemistry 14(20), 4497-4503 (1975).
39. Kosower NS, Kosower EM. The glutathione status of cells. Int. Rev. Cytol. 54, 109-160 (1978).
40. Carey DJ. Syndecans: multifunctional cell-surface co-receptors. Biochem. J. 327(Pt 1), 1-16 (1997).
41. Marie PJ. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 316, 23-32 (2003).
42. Varkey M, Kucharski C, Haque T, Sebald W, Uludag H. In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments. Clin. Orthop. Relat. Res. 443, 113-123 (2006).
43. Berglundh T, Abrahamsson I, Lang NP, Lindhe J. De novo alveolar bone formation adjacent to endosseous implants. Clin. Oral Implants Res. 14(3), 251-262 (2003).
44. Albelda SM, Buck CA. Integrins and other cell-adhesion molecules. Faseb J. 4(11), 2868-2880 (1990).
45. Owen TA, Aronow M, Shalhoub V et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 143(3), 420-430 (1990).
46. Cavalcanti-Adam EA, Shapiro IM, Composto RJ, Macarak EJ, Adams CS. RGD peptides immobilized on a mechanically deformable surface promote osteoblast differentiation. J. Bone Miner. Res. 17(12), 2130-2140 (2002).
47. Komori T. Regulation of osteoblast differentiation by Runx2. Adv. Exp. Med. Biol. 658, 43-49 (2010).
48. Mandal CC, Drissi H, Choudhury GG, Ghosh-Choudhury N. Integration of phosphatidylinositol 3-kinase, Akt kinase, and Smad signaling pathway in BMP-2-induced osterix expression. Calcif. Tissue Int. 87(6), 533-540 (2010).
49. Stein GS, Lian JB, Stein JL, Vanwijnen AJ, Montecino M. Transcriptional control of osteoblast growth and differentiation. Physiol. Rev. 76(2), 593-629 (1996).
50. Miraoui H, Oudina K, Petite H, Tanimoto Y, Moriyama K, Marie PJ. Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling. J. Biol. Chem. 284(8), 4897-4904 (2009).
51. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, Ryoo HM. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J. Biol. Chem 278(1), 319-326 (2003).
52. Pun S, Dearden RL, Ratkus AM, Liang H, Wronski TJ. Decreased bone anabolic effect of basic fibroblast growth factor at fatty marrow sites in ovariectomized rats. Bone 28(2), 220-226 (2001).
53. McCarthy TL, Centrella M, Canalis E. Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. Endocrinology 125(4), 2118-2126 (1989).
54. Hughes FJ, Turner W, Belibasakis G, Martuscelli G. Effects of growth factors and cytokines on osteoblast differentiation. Periodontol. 2000 41, 48-72 (2006).
55. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl Acad. Sci. USA 83(19), 7297-7301 (1986).